miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1

FASEB Journal

Volumn 27, Issue 3, 2013, Pages 1223-1235

  Cimino, Daniela ^a   De Pittà, Cristiano ^c   Orso, Francesca ^a   Zampini, Matteo ^c   Casara, Silvia ^c   Penna, Elisa ^a   Quaglino, Elena ^a,b   Forni, Marco ^a   Damasco, Christian ^a   Pinatel, Eva ^a   Ponzone, Riccardo ^d   Romualdi, Chiara ^c   Brisken, Cathrin ^e   De Bortoli, Michele ^a   Biglia, Nicoletta ^a   Provero, Paolo ^a   Lanfranchi, Gerolamo ^a,c   Taverna, Daniela ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d CANDIOLO CANCER INSTITUTE   (Italy)

^e National Center of Competence in Research in Molecular Oncology   (Switzerland)

Author keywords

Integrin signaling; Malignancy; Mammary tumor; microRNA profiling; Prognosis

Indexed keywords

ALPHA5 INTEGRIN; CISPLATIN; COLONY STIMULATING FACTOR 1; DOXORUBICIN; MICRORNA; MICRORNA 148B; PACLITAXEL; PROTEIN 110 ALPHA; PROTEIN P110; RHO KINASE; RHO KINASE 1; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CELL DEATH; CELL INVASION; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CIRCULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG RESPONSE; EXTRAVASATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE N RAS; PRIORITY JOURNAL; PROTEIN TARGETING; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; STABLE EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; INTEGRIN ALPHA5; MACROPHAGE COLONY-STIMULATING FACTOR; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; ONCOGENE PROTEIN P21(RAS); PHOSPHATIDYLINOSITOL 3-KINASES; RHO-ASSOCIATED KINASES; RNA, NEOPLASM;

EID: 84874626235     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-214692     Document Type: Article

References (50)

1. Liu, S., Clouthier, S. G., and Wicha, M. S. Role of microRNAs in the regulation of breast cancer stem cells. J. Mammary Gland Biol. Neoplasia 17, 15-21
2. Dunnwald, L. K., Rossing, M. A., and Li, C. I. (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 9, R6
3. Colozza, M., Cardoso, F., Sotiriou, C., Larsimont, D., and Piccart, M. J. (2005) Bringing molecular prognosis and prediction to the clinic. Clin. Breast Cancer 6, 61-76 (Pubitemid 40872948)
4. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., and Borresen-Dale, A. L. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98, 10869-10874 (Pubitemid 32878711)
5. Sotiriou, C., and Piccart, M. J. (2007) Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat. Rev. Cancer 7, 545-553 (Pubitemid 46985399)
6. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
7. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R., and Golub, T. R. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (Pubitemid 40839735)
8. Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S. F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., Tavare, S., Caldas, C., and Miska, E. A. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8, R214
9. Enerly, E., Steinfeld, I., Kleivi, K., Leivonen, S. K., Aure, M. R., Russnes, H. G., Ronneberg, J. A., Johnsen, H., Navon, R., Rodland, E., Makela, R., Naume, B., Perala, M., Kallioniemi, O., Kristensen, V. N., Yakhini, Z., and Borresen-Dale, A. L. miRNAmRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 6, e16915
10. Shi, M., Liu, D., Duan, H., Shen, B., and Guo, N. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev. 29, 785-799
11. Le, X. F., Merchant, O., Bast, R. C., and Calin, G. A. The roles of MicroRNAs in the cancer invasion-metastasis cascade. Cancer Microenviron. 3, 137-147
12. Penna, E., Orso, F., Cimino, D., Tenaglia, E., Lembo, A., Quaglino, E., Poliseno, L., Haimovic, A., Osella-Abate, S., De Pitta, C., Pinatel, E., Stadler, M. B., Provero, P., Bernengo, M. G., Osman, I., and Taverna, D. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J. 30, 1990-2007
13. Minn, A. J., Kang, Y., Serganova, I., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R., and Massague, J. (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44-55 (Pubitemid 40385504)
14. Simpson, J. F., Gray, R., Dressler, L. G., Cobau, C. D., Falkson, C. I., Gilchrist, K. W., Pandya, K. J., Page, D. L., and Robert, N. J. (2000) Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J. Clin. Oncol. 18, 2059-2069 (Pubitemid 30324359)
15. Tarone, G., Russo, M. A., Hirsch, E., Odorisio, T., Altruda, F., Silengo, L., and Siracusa, G. (1993) Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. Development 117, 1369-1375 (Pubitemid 23154501)
16. Laukaitis, C. M., Webb, D. J., Donais, K., and Horwitz, A. F. (2001) Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J. Cell Biol. 153, 1427-1440 (Pubitemid 34286127)
17. Wang, X., Tian, W., and Li, Y. (2008) Development of an efficient protocol of RNA isolation from recalcitrant tree tissues. Mol. Biotechnol. 38, 57-64 (Pubitemid 351378096)
18. Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (Pubitemid 36181903)
19. Risso, D., Massa, M. S., Chiogna, M., and Romualdi, C. (2009) A modified LOESS normalization applied to microRNA arrays: a comparative evaluation. Bioinformatics 25, 2685-2691
20. Tibshirani, R., Hastie, T., Narasimhan, B., and Chu, G. (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U. S. A. 99, 6567-6572 (Pubitemid 34526173)
21. Saeed, A. I., Bhagabati, N. K., Braisted, J. C., Liang, W., Sharov, V., Howe, E. A., Li, J., Thiagarajan, M., White, J. A., and Quackenbush, J. (2006) TM4 microarray software suite. Methods Enzymol. 411, 134-193
22. Liu, Y. (2008) Box plots: use and interpretation. Transfusion 48, 2279-2280
23. Zweig, M. H., and Campbell, G. (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561-577 (Pubitemid 23118304)
24. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163-170
25. Gill, R. (1982) Understanding Cox's regression model. Exper. Suppl. 41, 187-199
26. Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M., Atkins, D., and Foekens, J. A. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679 (Pubitemid 40260888)
27. Damasco, C., Lembo, A., Somma, M. P., Gatti, M., Di Cunto, F., and Provero, P. A signature inferred from Drosophila mitotic genes predicts survival of breast cancer patients. PLoS One 6, e14737
28. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (Pubitemid 40094598)
29. Mierke, C. T., Frey, B., Fellner, M., Herrmann, M., and Fabry, B. Integrin alpha5beta1 facilitates cancer cell invasion through enhanced contractile forces. J. Cell Sci. 124, 369-383
30. Desgrosellier, J. S., and Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22
31. Abraham, D., Zins, K., Sioud, M., Lucas, T., Schafer, R., Stanley, E. R., and Aharinejad, S. Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma. Int. J. Cancer 126, 1339-1352
32. Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schafer, R., Stanley, E. R., and Abraham, D. (2004) Colonystimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 64, 5378-5384 (Pubitemid 39006559)
33. Nam, J. M., Chung, Y., Hsu, H. C., and Park, C. C. (2009) beta1 integrin targeting to enhance radiation therapy. Int. J. Radiat. Biol. 85, 923-928
34. Mattie, M. D., Benz, C. C., Bowers, J., Sensinger, K., Wong, L., Scott, G. K., Fedele, V., Ginzinger, D., Getts, R., and Haqq, C. (2006) Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 5, 24
35. Ma, L., and Weinberg, R. A. (2008) Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet. 24, 448-456
36. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F., and Weinberg, R. A. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res. 70, 5147-5154
37. Tavazoie, S. F., Alarcon, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., and Massague, J. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152
38. Valastyan, S., Benaich, N., Chang, A., Reinhardt, F., and Weinberg, R. A. (2009) Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev. 23, 2592-2597
39. Taverna, D., and Hynes, R. O. (2001) Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies. Cancer Res. 61, 5255-5261 (Pubitemid 32681561)
40. Liu, S., Goldstein, R. H., Scepansky, E. M., and Rosenblatt, M. (2009) Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res. 69, 8742-8751
41. Lane, J., Martin, T. A., Watkins, G., Mansel, R. E., and Jiang, W. G. (2008) The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int. J. Oncol. 33, 585-593
42. Zheng, B., Liang, L., Wang, C., Huang, S., Cao, X., Zha, R., Liu, L., Jia, D., Tian, Q., Wu, J., Ye, Y. W., Wang, Q., Long, Z., Zhou, Y., Du, C., He, X., and Shi, Y. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin. Cancer Res. 17, 7574-7583
43. Renner, O., Blanco-Aparicio, C., Grassow, M., Canamero, M., Leal, J. F., and Carnero, A. (2008) Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation. Cancer Res. 68, 9643-9653
44. Eichhorn, P. J., Gili, M., Scaltriti, M., Serra, V., Guzman, M., Nijkamp, W., Beijersbergen, R. L., Valero, V., Seoane, J., Bernards, R., and Baselga, J. (2008) Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVPBEZ235. Cancer Res. 68, 9221-9230
45. Miller, T. W., Hennessy, B. T., Gonzalez-Angulo, A. M., Fox, E. M., Mills, G. B., Chen, H., Higham, C., Garcia-Echeverriav C., Shyr, Y., and Arteaga, C. L. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer. J. Clin. Invest. 120, 2406-2413
46. Eskandarpour, M., Kiaii, S., Zhu, C., Castro, J., Sakko, A. J., and Hansson, J. (2005) Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells. Int. J. Cancer 115, 65-73 (Pubitemid 40559669)
47. Nista, A., Leonetti, C., Bernardini, G., Mattioni, M., and Santoni, A. (1997) Functional role of alpha4beta1 and alpha5beta1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int. J. Cancer 72, 133-141 (Pubitemid 27314650)
48. Shi, J., and Wei, L. (2007) Rho kinase in the regulation of cell death and survival. Arch. Immunol. Ther. Exp. (Warsz.) 55, 61-75 (Pubitemid 46559196)
49. Lin, S. L., Chiang, A., Chang, D., and Ying, S. Y. (2008) Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14, 417-424 (Pubitemid 351397806)
50. Ma, L., Teruya-Feldstein, J., and Weinberg, R. A. (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (Pubitemid 47552092)